Jiri Bartek
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Cell Biology top 2%
- Microtubule and mitosis dynamics
Papers in
- Oncology 13
- Cancer-related Molecular Pathways 12
-
- Microtubule and mitosis dynamics 4
- Co-authors
- Jiřina Bártková (4 shared papers)Mike Strauss (2 shared papers)Andrew M. Fry (1 shared paper)Patrick Meraldi (1 shared paper)Erich A. Nigg (1 shared paper)Mikkel Rohde (1 shared paper)Kristian Helin (2 shared papers)Jiří Lukáš (2 shared papers)
In The Last Decade
Jiri Bartek
15 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 78
- Oncology 1.4k
- Cell Biology 689
- Molecular Biology 1.5k
- Biotechnology 188
- Cancer Research 244
Countries citing papers authored by Jiri Bartek
This map shows the geographic impact of Jiri Bartek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiri Bartek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiri Bartek more than expected).
Fields of papers citing papers by Jiri Bartek
This network shows the impact of papers produced by Jiri Bartek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiri Bartek. The network helps show where Jiri Bartek may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiri Bartek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 403 | |
| 2 | 1996 | 342 | |
| 3 | 1995 | 322 | |
| 4 | 1996 | 249 | |
| 5 | Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. | 1994 | 229 |
| 6 | 1997 | 212 | |
| 7 | 1995 | 141 | |
| 8 | 1997 | 107 | |
| 9 | 2000 | 58 | |
| 10 | 2000 | 45 | |
| 11 | 2023 | 44 | |
| 12 | p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells. | 1998 | 28 |
| 13 | 2018 | 25 | |
| 14 | 2000 | 15 | |
| 15 | 1996 | 4 | |
| 16 | 2025 | 0 |
About Jiri Bartek
Jiri Bartek is a scholar working on Oncology, Cell Biology, Ophthalmology, Genetics and Genetics, having authored 16 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (4 papers), Ubiquitin and proteasome pathways (4 papers), Virus-based gene therapy research (2 papers), Ocular Oncology and Treatments (2 papers), Glioma Diagnosis and Treatment (2 papers), Testicular diseases and treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Oncology (1.4k citations), Cell Biology (689 citations), Molecular Biology (1.5k citations), Biotechnology (188 citations) and Cancer Research (244 citations). Jiri Bartek has collaborated with scholars based in Denmark, Germany and Sweden. Frequent co-authors include Jiřina Bártková, Mike Strauss, Andrew M. Fry, Patrick Meraldi, Erich A. Nigg, Mikkel Rohde, Kristian Helin, Jiří Lukáš, Karin Holm and Birgit Otzen Petersen. Their work appears in journals such as Molecular and Cellular Biology, Nature Medicine, F1000Research, The Journal of Pathology and Current Opinion in Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.